Clinical Trial Update: Evaluation of TK3 in Improving Quality of Life in Patients With Malignancy Under Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating TK3 to improve quality of life in cancer patients undergoing chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• TK3

Snippet

Sponsor: Lavilabor Natural Products Ltd | Conditions: Cancer | Phase 3 | Status: UNKNOWN